Rheumatology experts urge caution in using bisphosphonates to prevent bone loss
Search results for: cardiovascular disease
Rheumatology Drug Updates: Apremilast, Golimumab, and More
Information on new approvals and medication safety rheumatologists need to know
Fellow’s Forum Case Report: True Vasculitis or Vasculitis Mimic?
Rheumatologists face the emerging picture of cocaine and levamisole-associated vasculopathy in clinical practice
American College of Rheumatology Award Provides Researchers Time for Career Development
The ACR Research and Education Foundation (REF) initiated the ACR REF Rheumatology Investigator Award, which supports junior investigators as they are developing a project that will compete for NIH funding.
EULAR 2012: Remission the New Normal for Rheumatoid Arthritis
Advances in the rheumatology clinic are promising, two experts say.
Drug Updates
Information on new approvals and medication safety.
Tech Talk: Tapping Computer Power to Promote Physical Therapy
Physical therapy for rheumatoid arthritis patients is crucial to treating their disease. A group of researchers is trying to harness the power of computer technology to make physical therapy something that patients look forward to.
Coding Corner: May’s Coding Challenge
A 54-year-old female with rheumatoid arthritis is seen by the rheumatologist for a follow-up visit.
Reflections on Living with Lupus, and on Treating It
There are some people whose purpose in life is to entertain. Some of us are fortunate to have them as our patients.
Unexpected Benefits of Bisphosphonates after Hip Fracture
Recent trials show this bisphosphonates can reduce subsequent hip fractures and mortality, while remaining cost effective.
- « Previous Page
- 1
- …
- 57
- 58
- 59
- 60
- 61
- …
- 64
- Next Page »